Table 5 Clinical characteristics and outcomes of patients and studies in the two different time periods
Variables (Weighted average) | TOTAL (Nº studies = 171) (Nº cases = 15,178) | 1990–2015 (Nº studies = 89) (Nº cases = 6,260) | 2016–2024 (Nº studies = 82) (Nº cases = 8,918) | p * |
|---|---|---|---|---|
Age (years) | 75.3 ± 13.9 | 70.2 ± 12.3 | 77.7 ± 13.6 | 0.0115 |
BMI (Kg/m2) | 26.9 ± 3.1 | 26.6 ± 4.2 | 27.3 ± 2.2 | 0.4673 |
Total leukocytes (10e3/uL) | 15,056 ± 6,008 | 17,291 ± 6,464 | 17,417 ± 5,397 | 0.9433 |
Creatinine (mg/dL) | 2.1 ± 1.2 | 2.8 ± 0.9 | 1.9 ± 1.3 | 0.2162 |
Lactate (mml/l) | 2.6 ± 0.9 | 3.0 ± 0.2 | 2.5 ± 0.8 | 0.4054 |
Intratoracic stomach volume (%) | 84.1 ± 17.1 | 78.4 ± 16.4 | 80.1 ± 13.2 | 0.6973 |
Gastric tube production (cc) | 1,896 ± 1,827 | 1,714 ± 942 | 1,920 ± 2,175 | 0.3883 |
Emergency surgery& (%) | Â | Â | Â | Â |
 Yes  No | 61.1 38.9 | 68.1 31.9 | 55.6 44.4 | 0.003 |
Laparoscopic approach (%) | Â | Â | Â | Â |
 Yes  No | 12.7 87.3 | 30.1 69.9 | 7.6 92.4 | < 0.001 |
Surgical time (min) | 165 ± 67 | 198 ± 77 | 140 ± 67 | 0.0860 |
Length of hospital stay (days) | 7.9 ± 5.3 | 8.2 ± 2.7 | 7.9 ± 6.1 | 0.4611 |
POC (%) | 32.0 ± 24.1 | 33.0 ± 24.8 | 28.4 ± 23.1 | 0.1632 |
Re-interventions (%) | 7.6 ± 2.6 | 3.2 ± 3.5 | 14.9 ± 8.6 | 0.0350 |
30DM (%) | 5.7 ± 2.9 | 4.1 ± 3.4 | 6.7 ± 5.9 | 0.2841 |
Readmissions (%) | 11.0 ± 7.7 | 56.9 ± 6.6 | 11.5 ± 7.4 | 0.0001 |
Follow-up (months) | 15.7 ± 10.7 | 14.6 ± 9.8 | 17.0 ± 11.9 | 0.2146 |
Recurrence (%) | 22.2 ± 5.9 | 16.4 ± 4.6 | 8.9 ± 6.7 | 0.0083 |
MQ MInCir-T scale (points) | 8.9 ± 2.3 | 9.1 ± 2.6 | 8.9 ± 2.2 | 0.5943 |
MQ MInCir-Pr2 scale (points) | 13.4 ± 5.4 | 13.3 ± 5.4 | 13.5 ± 5.4 | 0.8161 |